Select Committee · Business and Trade Committee

Brexit and the implications for UK business: Pharmaceuticals inquiry

Status: Closed Opened: 20 Sep 2017 Closed: 14 Sep 2017 1 report

This is the pharmaceuticals strand of the Committee's Brexit and the implications for UK business inquiry . The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, …

Reports

1 report
Title HC No. Published Items Response
9th Report - The impact of Brexit on the pharmaceutical sec… HC 382 17 May 2018 0 Responded

Oral evidence sessions

1 session
Date Witnesses
5 Dec 2017 Session View ↗